Abstract: The present disclosure provides an aerial system, comprising: a body; a lift mechanism coupled to the body; an optical system coupled to the body; and a computer system having at least one processor and at least one memory comprising first program instructions. When the first program instructions are executed by the at least one processor, the at least one processor may be configured to: receive a target operation, the target operation associated with a flight trajectory and a predefined action performed by the optical system and execute the target operation.

Abstract: An apparatus may include at least one memory, and at least one processor configured to determine an accessibility of a first version of a page, wherein the first version of the page may be stored in the at least one memory, and perform, based on the accessibility of the first version of the page, an access of at least a portion of a second version of the page, wherein the second version of the page is stored in the at least one memory. The accessibility of the first version of the page may be based on an erase operation of the first version of the page. The access of the at least a portion of the second version of the page may include an access of a cache line of the second version of the page.

Abstract: A system and method for inference using an embedding table. In some embodiments, the method includes forming a culled index vector including a first index, and requesting a weight vector corresponding to the first index. The first index may be a first element of a first index vector, the first index being culled within the culled index vector.

Abstract: The present disclosure describes a method, apparatus, and storage medium for generating network representation for a neural network. The method includes obtaining a source-side vector sequence corresponding to an input sequence.

Abstract: The invention is directed to T cells and other cells that express chimeric NK-p30 receptors (“chimeric NKp30 T cells”), methods of making and using chimeric NKp30 T cells, and methods of using these chimeric NKp30 T cells, isolated populations thereof, and compositions comprising the same. In another aspect, said chimeric NKp30 T cells are further designed to express a functional non-TCR receptor. The disclosure also pertains to methods of making said chimeric NKp30 T cells, and methods of reducing or ameliorating, or preventing or treating, diseases and disorders using said chimeric NKp30 T cells, populations thereof, or compositions comprising the same.

Abstract: The present disclosure provides a speaker including a housing and a vibration system and a magnetic circuit unit that are received in the housing. The magnetic circuit unit includes lower clamp plate and magnetic circuit assembly arranged on lower clamp plate. A central area of lower clamp plate abuts against bottom wall of the housing. An edge area of lower clamp plate is spaced from the bottom wall. The edge area is provided with flange portion bending and extending from lower clamp plate toward the bottom wall. The flange portion abuts against the bottom wall. The flange portion abuts against the bottom wall. In this way, when speaker falls off, flange portions come in contact with bottom wall, such that stability of magnetic circuit unit can be improved, then operational performance and service life can be improved.

Abstract: The present invention relates to chimeric immune receptor molecules for reducing or eliminating tumors. The chimeric receptors are composed a C-type lectin-like natural killer cell receptor, or a protein associated therewith, fused to an immune signaling receptor containing an immunoreceptor tyrosine-based activation motif. Methods for using the chimeric receptors are further provided.

Abstract: The present disclosure provides a negative electrode material, a preparation method thereof, and an all-solid-state lithium battery. The negative electrode material includes a core and an amorphous lithium-silicon alloy layer cladding the core. The core includes a glassy solid electrolyte and amorphous lithium-silicon alloy particles dispersed in the glassy solid electrolyte. The material of the amorphous lithium-silicon alloy particles is LixSi, 0<x?4.4. The material of the amorphous lithium-silicon alloy layer is LiySi, 0<y?4.4.

Abstract: A method of establishing an image set for image recognition includes obtaining a single-label image set comprising an image annotated with a single label, and a multi-label image set comprising an image annotated with a plurality of labels; converting content of each label into a corresponding word identifier according to a semantic network, to obtain a word identifier set, a converted single-label image set, and a converted multi-label image set; and constructing a hierarchical semantic structure according to the word identifier set and the semantic network. The method also includes performing label supplementation on the image in the converted single-label image set to obtain a supplemented single-label image set; performing label supplementation on the supplemented single-label image set to obtain a final supplemented image set; and establishing a target multi-label image set to train an image recognition model by using the target multi-label image set.

Abstract: A method and redundant array of independent disks (RAID) system are provided. An operation is received from an application at a file system (FS) of the RAID system. A memory mapping module of the RAID system receives at least an FS logical block address (LBA) in accordance with the operation. The memory mapping module creates a mapping from a virtual memory of the application to a RAID array in a system memory of the RAID system using at least the FS LBA.

Abstract: A system is disclosed. A first storage device may supporting a cache coherent interconnect protocol, the cache coherent interconnect protocol including a block level protocol and a byte level protocol. A second storage device may also support the cache coherent interconnect protocol. A redundant array of independent disks (RAID) circuit may communicate with the first storage device and the second storage device. The RAID circuit may apply a RAID level to the first storage device and the second storage device. The RAID circuit may be configured to receive a request using the byte level protocol and to access data on the first storage device.

Abstract: A system is disclosed. The system may include a processor that may issue a byte level protocol request including a byte address. The system may also include a first storage device and a second storage device. The first storage device and the second storage device may support a cache coherent interconnect protocol, the cache coherent interconnect protocol including a block level protocol and a byte level protocol. The first storage device and the second storage device are included in a redundant array of independent disks (RAID). The first storage device may include a first address range, and the second storage device may include a second address range. The second storage device may provide a RAID address range associated with the first address range and the second address range. A decoder associated with the second storage device may be configured to receive the request from the processor. The decoder may determine that the byte address in the RAID address range is associated with a target address range.

Abstract: The present disclosure provides IL2 proproteins comprising an IL2 moiety that is masked with an IL2R? moiety and a protease-cleavable linker, configured such that the IL2R? moiety is released from the IL2 moiety upon the action of a protease, e.g., at a tumor site. The IL2 proproteins optionally further comprise a targeting moiety, e.g., a targeting moiety that recognizes a tumor-associated antigen and directs the proprotein to a tumor site. The disclosure further provides pharmaceutical compositions comprising the IL2 proproteins, and methods of use of the IL2 proproteins in therapy, as well as nucleic acids encoding the IL2 proproteins, recombinant cells that express the IL2 proproteins and methods of producing the IL2 proproteins.

Abstract: Provided are methods of treating cancer or increasing, enhancing, or stimulating an immune response with antibodies that specifically bind to TIGIT (T cell immunoreceptor with Ig and ITIM domains, WUCAM or Vstm3) and antigen-binding fragments thereof in combination with an anti-PD1 antibody.

Abstract: An intelligent experimental device for collaborative mining of associated resources includes a signal transmission mechanism, a pressure maintaining mechanism, a feeding mechanism, and a reaction mechanism. The signal transmission mechanism includes a centralized controller, an annunciator, signal receivers, a power supply, a power cord, signal transmitters, and signal sensing valves. The pressure maintaining mechanism includes ambient and axial pressure oil chambers, ambient and axial pressure pumps, ambient and axial pressure liquid distribution tanks, a comprehensive pressure distribution pipe, and hydraulic transmission pipes. The feeding mechanism includes monitoring analyzers, temperature controllers, solution transfer pipes, seepage pumps, mixture conveying pipes, a comprehensive liquid distributor, an aggregate chamber, a liquid chamber, an oil chamber, a gas chamber, a mixing chamber and an analytical purifier.

Abstract: An electronic device, including a first circuit, a second circuit, a coil, and one or more resonant circuits. The first circuit may transmit a first signal through the coil, and the second circuit may transmit a second signal through the coil. Frequencies of the first signal and the second signal are different. The resonant circuit may be disposed between the first circuit and the coil to prevent the second signal from passing or disposed between the second circuit and the coil to prevent the first signal from passing, so as to prevent the first signal from interfering with the second circuit or prevent the second signal from interfering with the first circuit.

Abstract: This disclosure relates to IL-2 variants and methods of use thereof, including methods of treating or inhibiting a cancer or tumor. The IL-2 variants may have reduced ability in binding to or activating IL-2R?. The IL-2 variants may retain the ability in binding to or activating IL-2R? and/or IL-2R??. In addition, the IL-2 variants may have decreased Treg activity but maintain the capacity to activate NK cells and T effector cells.

Abstract: The present invention provides a coal-based solid waste transport and filling integrated machine mining system, comprising a filling hydraulic support (6) and a coal winning machine (7), said filling hydraulic support (6) comprises a hydraulic top plate and a base (601), said hydraulic top plate comprises a hinged front top beam (602) and a rear top beam (603), with a front probe beam (604) attached to front end of said front top beam (602) and a telescopic slide rod (1) connected to rear end of said rear top beam (603), a double transport and single filling non-stop equipment is fixed on the telescopic slide rod (1). The apparatus and method of the present invention weaken the impact of groundwater pollution on mine production and mine ecology, bring good economic and environmental benefits to the mine and promoting safe and green coal mining.

Abstract: The present disclosure provides IL2 proproteins comprising an IL2 moiety that is masked with an IL2R? moiety and a protease-cleavable linker, configured such that the IL2R? moiety is released from the IL2 moiety upon the action of a protease, e.g., at a tumor site. The IL2 proproteins optionally further comprise a targeting moiety, e.g., a targeting moiety that recognizes a tumor-associated antigen and directs the proprotein to a tumor site. The disclosure further provides pharmaceutical compositions comprising the IL2 proproteins, and methods of use of the IL2 proproteins in therapy, as well as nucleic acids encoding the IL2 proproteins, recombinant cells that express the IL2 proproteins and methods of producing the IL2 proproteins.

Abstract: A method for the prevention, delay of progression or treatment of cancer in a subject, comprising administering to the subject in need thereof a Btk inhibitor, particularly, (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazo-lo[1,5-a]pyrimidine-3-carboxamide or a pharmaceutically acceptable salt thereof, in combination with an immune checkpoint inhibitor or a targeted therapy agent. A pharmaceutical combination comprising a Btk inhibitor, particularly, (S)-7-(1-acryloylpiperidin-4-yl)-2-( 4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide or a pharmaceutically acceptable salt thereof, in combination with an immune checkpoint inhibitor or a targeted therapy agent.